SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-045904
Filing Date
2024-05-22
Accepted
2024-05-22 16:15:19
Documents
7
Period of Report
2024-05-22

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0206358-6k_canfite.htm 6-K 14121
2 NOTICE AND PROXY STATEMENT WITH RESPECT TO THE COMPANY'S ANNUAL GENERAL MEETING ea020635801ex99-1_canfite.htm EX-99.1 113134
3 PROXY CARD FOR HOLDERS OF ORDINARY SHARES WITH RESPECT TO THE COMPANY'S ANNUAL G ea020635801ex99-2_canfite.htm EX-99.2 28876
4 VOTING INSTRUCTION CARD FOR AMERICAN DEPOSITARY SHAREHOLDERS WITH RESPECT TO THE ea020635801ex99-3_canfite.htm EX-99.3 1536
5 GRAPHIC ex99-1_001.jpg GRAPHIC 10592
6 GRAPHIC ex99-3_001.jpg GRAPHIC 183595
7 GRAPHIC ex99-3_002.jpg GRAPHIC 128886
  Complete submission text file 0001213900-24-045904.txt   604031
Mailing Address 26 BEN GURION STREET RAMAT GAN L3 5257346
Business Address 26 BEN GURION STREET RAMAT GAN L3 5257346 972 39241114
Can-Fite BioPharma Ltd. (Filer) CIK: 0001536196 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36203 | Film No.: 24973442
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)